Quantum Biopharma's Financial Performance Surges in 2024 with Enhanced Liquidity, Operational Efficiency, and Resolution of Going Concern Concerns
Quantum Biopharma reports strong 2024 financials, with improvements in cash working capital, operating efficiency and removal of material uncertainty related to going concern.